| GO ID | GO:0008285 |
| Ontology | BP |
| GO Term | negative regulation of cell proliferation |
| Definition | Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ABI1 | abl interactor 1 |
10006 | Q8IZP0 | chr10: 26,746,593-26,861,087 |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
9510 | Q9UHI8 | chr21: 26,835,747-26,845,409 |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif 8 |
11095 | Q9UP79 | chr11: 130,404,925-130,428,993 |
ADARB1 | adenosine deaminase, RNA-specific, B1 |
104 | P78563 | chr21: 45,073,853-45,226,560 |
ADGRG1 | adhesion G protein-coupled receptor G1 |
9289 | Q9Y653 | chr16: 57,610,652-57,665,580 |
ADM | adrenomedullin |
133 | P35318 | chr11: 10,304,680-10,307,397 |
ADORA1 | adenosine A1 receptor |
134 | P30542 | chr1: 203,090,654-203,167,405 |
ADRA1A | adrenoceptor alpha 1A |
148 | P35348 | chr8: 26,748,150-26,867,273 |
ALDH1A2 | aldehyde dehydrogenase 1 family member A2 |
8854 | O94788 | chr15: 57,953,424-58,497,866 |
APC | adenomatous polyposis coli |
324 | P25054 | chr5: 112,707,498-112,846,239 |
AR | androgen receptor |
367 | P10275 | chrX: 67,544,032-67,730,619 |
AZGP1 | alpha-2-glycoprotein 1, zinc-binding |
563 | P25311 | chr7: 99,966,720-99,976,157 |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
2683 | P15291 | chr9: 33,104,082-33,167,356 |
BAP1 | BRCA1 associated protein 1 |
8314 | Q92560 | chr3: 52,401,013-52,410,350 |
BCL6 | B-cell CLL/lymphoma 6 |
604 | P41182 | chr3: 187,721,377-187,745,727 |
BMP2 | bone morphogenetic protein 2 |
650 | P12643 | chr20: 6,767,664-6,780,280 |
BMP4 | bone morphogenetic protein 4 |
652 | P12644 | chr14: 53,949,736-53,958,761 |
BRD7 | bromodomain containing 7 |
29117 | Q9NPI1 | chr16: 50,313,487-50,368,934 |
BTG1 | B-cell translocation gene 1, anti-proliferative |
694 | P62324 | chr12: 92,140,278-92,145,897 |
BTG2 | BTG family member 2 |
7832 | P78543 | chr1: 203,305,491-203,309,602 |
CD164 | CD164 molecule, sialomucin |
8763 | Q04900 | chr6: 109,366,514-109,382,457 |
CD33 | CD33 molecule |
945 | P20138 | chr19: 51,225,064-51,243,860 |
CD9 | CD9 molecule |
928 | P21926 | chr12: 6,199,715-6,238,271 |
CDC6 | cell division cycle 6 |
990 | Q99741 | chr17: 40,287,633-40,304,657 |
CDH13 | cadherin 13 |
1012 | P55290 | chr16: 82,626,803-83,800,640 |
CDH5 | cadherin 5, type 2 (vascular endothelium) |
1003 | P33151 | chr16: 66,366,622-66,404,786 |
CDK10 | cyclin-dependent kinase 10 |
8558 | Q15131 | chr16: 89,680,737-89,696,364 |
CDK6 | cyclin-dependent kinase 6 |
1021 | Q00534 | chr7: 92,604,921-92,836,594 |
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 | P38936 | chr6: 36,676,460-36,687,339 |
CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
1027 | P46527 | chr12: 12,715,058-12,722,371 |
CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
1030 | P42772 | chr9: 22,002,903-22,009,363 |
CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
1031 | P42773 | chr1: 50,960,745-50,974,633 |
CDKN3 | cyclin-dependent kinase inhibitor 3 |
1033 | Q16667 | chr14: 54,396,849-54,420,218 |
CHERP | calcium homeostasis endoplasmic reticulum protein |
10523 | Q8IWX8 | chr19: 16,517,889-16,542,530 |
CIB1 | calcium and integrin binding 1 |
10519 | Q99828 | chr15: 90,229,975-90,234,047 |
CNOT7 | CCR4-NOT transcription complex subunit 7 |
29883 | Q9UIV1 | chr8: 17,224,964-17,246,878 |
COL18A1 | collagen, type XVIII, alpha 1 |
80781 | P39060 | chr21: 45,405,137-45,513,720 |
COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) |
1285 | Q01955 | chr2: 227,164,565-227,314,792 |
COPS8 | COP9 signalosome subunit 8 |
10920 | Q99627 | chr2: 237,085,312-237,100,466 |
CSF1R | colony stimulating factor 1 receptor |
1436 | P07333 | chr5: 150,053,291-150,113,372 |
CSK | c-src tyrosine kinase |
1445 | P41240 | chr15: 74,782,057-74,803,198 |
CTBP2 | C-terminal binding protein 2 |
1488 | P56545 | chr10: 124,984,317-125,161,170 |
CTNNB1 | catenin beta 1 |
1499 | P35222 | chr3: 41,194,837-41,260,096 |
CUL2 | cullin 2 |
8453 | Q13617 | chr10: 35,008,551-35,090,642 |
CUL4A | cullin 4A |
8451 | Q13619 | chr13: 113,208,193-113,267,108 |
CUL5 | cullin 5 |
8065 | Q93034 | chr11: 108,008,733-108,107,776 |
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
2919 | P09341 | chr4: 73,869,393-73,871,242 |
CXCL8 | chemokine (C-X-C motif) ligand 8 |
3576 | P10145 | chr4: 73,740,506-73,743,716 |
CYP1B1 | cytochrome P450 family 1 subfamily B member 1 |
1545 | Q16678 | chr2: 38,066,973-38,109,902 |
CYP27B1 | cytochrome P450 family 27 subfamily B member 1 |
1594 | O15528 | chr12: 57,762,334-57,768,986 |
DDR1 | discoidin domain receptor tyrosine kinase 1 |
780 | Q08345 | chr6: 30,876,421-30,900,156 |
DDX20 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 |
11218 | Q9UHI6 | chr1: 111,755,245-111,768,016 |
DHCR24 | 24-dehydrocholesterol reductase |
1718 | Q15392 | chr1: 54,849,633-54,887,218 |
DLC1 | DLC1 Rho GTPase activating protein |
10395 | Q96QB1 | chr8: 13,083,361-13,604,610 |
DLG5 | discs, large homolog 5 (Drosophila) |
9231 | Q8TDM6 | chr10: 77,790,791-77,926,526 |
DLL4 | delta-like 4 (Drosophila) |
54567 | Q9NR61 | chr15: 40,929,340-40,939,072 |
DRD2 | dopamine receptor D2 |
1813 | P14416 | chr11: 113,409,615-113,475,691 |
EEF1E1 | eukaryotic translation elongation factor 1 epsilon 1 |
9521 | O43324 | chr6: 8,073,360-8,102,578 |
EMP3 | epithelial membrane protein 3 |
2014 | P54852 | chr19: 48,321,509-48,330,553 |
ERBB4 | erb-b2 receptor tyrosine kinase 4 |
2066 | Q15303 | chr2: 211,375,717-212,538,841 |
EREG | epiregulin |
2069 | O14944 | chr4: 74,365,143-74,388,751 |
ETS1 | v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
2113 | P14921 | chr11: 128,458,761-128,587,558 |
F2R | coagulation factor II (thrombin) receptor |
2149 | P25116 | chr5: 76,716,043-76,735,781 |
FABP3 | fatty acid binding protein 3, muscle and heart |
2170 | P05413 | chr1: 31,365,625-31,376,850 |
FABP6 | fatty acid binding protein 6, ileal |
2172 | P51161 | chr5: 160,187,367-160,238,735 |
FOSL1 | FOS-like antigen 1 |
8061 | P15407 | chr11: 65,892,049-65,900,573 |
FOXO4 | forkhead box O4 |
4303 | P98177 | chrX: 71,096,197-71,103,535 |
FOXP3 | forkhead box P3 |
50943 | Q9BZS1 | chrX: 49,250,436-49,264,826 |
FTH1 | ferritin, heavy polypeptide 1 |
2495 | P02794 | chr11: 61,959,718-61,967,660 |
GDF11 | growth differentiation factor 11 |
10220 | O95390 | chr12: 55,743,280-55,757,278 |
GLI3 | GLI family zinc finger 3 |
2737 | P10071 | chr7: 41,960,950-42,237,870 |
GNRH1 | gonadotropin releasing hormone 1 |
2796 | P01148 | chr8: 25,419,260-25,424,654 |
GPER1 | G protein-coupled estrogen receptor 1 |
2852 | Q99527 | chr7: 1,082,208-1,093,815 |
GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 |
2822 | P80108 | chr6: 24,424,565-24,495,205 |
GPNMB | glycoprotein (transmembrane) nmb |
10457 | Q14956 | chr7: 23,235,967-23,275,108 |
HDAC1 | histone deacetylase 1 |
3065 | Q13547 | chr1: 32,292,086-32,333,635 |
HDAC4 | histone deacetylase 4 |
9759 | P56524 | chr2: 239,048,168-239,401,654 |
HIST1H2AC | histone cluster 1, H2ac |
8334 | Q93077 | chr6: 26,124,145-26,139,116 |
HMGA1 | high mobility group AT-hook 1 |
3159 | P17096 | chr6: 34,236,873-34,246,231 |
HSF1 | heat shock transcription factor 1 |
3297 | Q00613 | chr8: 144,291,591-144,314,722 |
IFITM1 | interferon induced transmembrane protein 1 |
8519 | P13164 | chr11: 313,506-315,272 |
IGFBP3 | insulin like growth factor binding protein 3 |
3486 | P17936 | chr7: 45,912,245-45,921,874 |
IGFBP6 | insulin like growth factor binding protein 6 |
3489 | P24592 | chr12: 53,097,436-53,102,345 |
IGFBP7 | insulin like growth factor binding protein 7 |
3490 | Q16270 | chr4: 57,030,773-57,110,385 |
IL10 | interleukin 10 |
3586 | P22301 | chr1: 206,767,602-206,772,494 |
IL1A | interleukin 1 alpha |
3552 | P01583 | chr2: 112,773,915-112,784,590 |
IL1B | interleukin 1 beta |
3553 | P01584 | chr2: 112,829,751-112,836,903 |
IL6 | interleukin 6 |
3569 | P05231 | chr7: 22,725,884-22,732,002 |
INHBA | inhibin beta A |
3624 | P08476 | chr7: 41,667,168-41,705,834 |
INSM1 | insulinoma associated 1 |
3642 | Q01101 | chr20: 20,368,121-20,370,949 |
IRF1 | interferon regulatory factor 1 |
3659 | P10914 | chr5: 132,481,609-132,490,798 |
IRF6 | interferon regulatory factor 6 |
3664 | O14896 | chr1: 209,785,623-209,806,175 |
ITGB1BP1 | integrin subunit beta 1 binding protein 1 |
9270 | O14713 | chr2: 9,403,475-9,423,547 |
JAK2 | Janus kinase 2 |
3717 | O60674 | chr9: 4,984,390-5,128,183 |
JUN | jun proto-oncogene |
3725 | P05412 | chr1: 58,780,788-58,784,327 |
KANK2 | KN motif and ankyrin repeat domains 2 |
25959 | Q63ZY3 | chr19: 11,164,267-11,197,791 |
KAT2B | K(lysine) acetyltransferase 2B |
8850 | Q92831 | chr3: 20,040,023-20,154,404 |
KIFAP3 | kinesin-associated protein 3 |
22920 | Q92845 | chr1: 169,921,326-170,085,208 |
KISS1 | KiSS-1 metastasis-suppressor |
3814 | Q15726 | chr1: 204,190,341-204,196,486 |
KLF10 | Kruppel-like factor 10 |
7071 | Q13118 | chr8: 102,648,779-102,655,902 |
KLF13 | Kruppel-like factor 13 |
51621 | Q9Y2Y9 | chr15: 31,326,855-31,435,665 |
KLF4 | Kruppel-like factor 4 (gut) |
9314 | O43474 | chr9: 107,484,852-107,490,482 |
LAS2 | lung adenoma susceptibility protein 2 |
162681 | Q8IYD9 | chr18: 54,357,917-54,385,218 |
LIF | leukemia inhibitory factor |
3976 | P15018 | chr22: 30,240,447-30,246,851 |
LYN | LYN proto-oncogene, Src family tyrosine kinase |
4067 | P07948 | chr8: 55,879,813-56,014,168 |
MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 |
9863 | Q86UL8 | chr7: 78,017,057-79,453,574 |
MAP2K1 | mitogen-activated protein kinase kinase 1 |
5604 | Q02750 | chr15: 66,386,817-66,492,312 |
MDM4 | MDM4, p53 regulator |
4194 | O15151 | chr1: 204,516,379-204,558,120 |
MNT | MAX network transcriptional repressor |
4335 | Q99583 | chr17: 2,384,060-2,401,118 |
MXD4 | MAX dimerization protein 4 |
10608 | Q14582 | chr4: 2,247,432-2,262,294 |
MXI1 | MAX interactor 1, dimerization protein |
4601 | P50539 | chr10: 110,207,605-110,287,365 |
NDRG1 | N-myc downstream regulated 1 |
10397 | Q92597 | chr8: 133,237,171-133,302,022 |
NF2 | neurofibromin 2 (merlin) |
4771 | P35240 | chr22: 29,603,556-29,698,598 |
NME1 | NME/NM23 nucleoside diphosphate kinase 1 |
4830 | P15531 | chr17: 51,153,536-51,162,428 |
NOS3 | nitric oxide synthase 3 |
4846 | P29474 | chr7: 150,990,995-151,014,588 |
NOTCH1 | notch 1 |
4851 | P46531 | chr9: 136,494,444-136,545,862 |
NOTCH2 | notch 2 |
4853 | Q04721 | chr1: 119,911,553-120,069,626 |
NOX4 | NADPH oxidase 4 |
50507 | Q9NPH5 | chr11: 89,324,356-89,498,187 |
NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
4869 | P06748 | chr5: 171,387,116-171,411,137 |
NRK | Nik related kinase |
203447 | Q7Z2Y5 | chrX: 105,822,543-105,958,610 |
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 |
4914 | P04629 | chr1: 156,815,640-156,881,850 |
NUP62 | nucleoporin 62kDa |
23636 | P37198 | chr19: 49,906,825-49,929,763 |
P3H2 | prolyl 3-hydroxylase 2 |
55214 | Q8IVL5 | chr3: 189,956,728-190,122,437 |
PBRM1 | polybromo 1 |
55193 | Q86U86 | chr3: 52,545,352-52,685,917 |
PDCD5 | programmed cell death 5 |
9141 | O14737 | chr19: 32,581,068-32,587,452 |
PDS5B | PDS5 cohesin associated factor B |
23047 | Q9NTI5 | chr13: 32,586,427-32,778,019 |
PEMT | phosphatidylethanolamine N-methyltransferase |
10400 | Q9UBM1 | chr17: 17,505,563-17,591,708 |
PHB | prohibitin |
5245 | P35232 | chr17: 49,404,049-49,414,905 |
PKD2 | polycystic kidney disease 2 (autosomal dominant) |
5311 | Q13563 | chr4: 88,007,668-88,077,777 |
PKP2 | plakophilin 2 |
5318 | Q99959 | chr12: 32,790,745-32,896,840 |
PLG | plasminogen |
5340 | P00747 | chr6: 160,702,238-160,753,315 |
PLPP1 | phospholipid phosphatase 1 |
8611 | O14494 | chr5: 55,424,854-55,535,050 |
PMP22 | peripheral myelin protein 22 |
5376 | Q01453 | chr17: 15,229,777-15,265,326 |
PODN | podocan |
127435 | Q7Z5L7 | chr1: 53,062,052-53,085,502 |
PPP2R5C | protein phosphatase 2 regulatory subunit B', gamma |
5527 | Q13362 | chr14: 101,761,798-101,927,989 |
PRKRA | protein kinase, interferon-inducible double stranded RNA dependent activator |
8575 | O75569 | chr2: 178,431,414-178,451,512 |
PROX1 | prospero homeobox 1 |
5629 | Q92786 | chr1: 213,983,181-214,041,502 |
PTEN | phosphatase and tensin homolog |
5728 | P60484 | chr10: 87,863,113-87,971,930 |
PTGES | prostaglandin E synthase |
9536 | O14684 | chr9: 129,738,331-129,753,047 |
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
5743 | P35354 | chr1: 186,671,791-186,680,427 |
PTHLH | parathyroid hormone-like hormone |
5744 | P12272 | chr12: 27,958,084-27,972,705 |
PTPN2 | protein tyrosine phosphatase, non-receptor type 2 |
5771 | P17706 | chr18: 12,785,478-12,929,643 |
PTPRJ | protein tyrosine phosphatase, receptor type, J |
5795 | Q12913 | chr11: 47,980,558-48,170,841 |
PTPRK | protein tyrosine phosphatase, receptor type, K |
5796 | Q15262 | chr6: 127,968,779-128,520,674 |
RAF1 | Raf-1 proto-oncogene, serine/threonine kinase |
5894 | P04049 | chr3: 12,583,601-12,664,226 |
RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 |
5918 | P49788 | chr3: 158,696,892-158,732,696 |
RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 |
83593 | Q8WWW0 | chr1: 206,507,530-206,589,448 |
RBBP4 | retinoblastoma binding protein 4 |
5928 | Q09028 | chr1: 32,651,142-32,686,211 |
RBM5 | RNA binding motif protein 5 |
10181 | P52756 | chr3: 50,088,908-50,119,021 |
RERG | RAS-like, estrogen-regulated, growth inhibitor |
85004 | Q96A58 | chr12: 15,107,783-15,348,675 |
RGCC | regulator of cell cycle |
28984 | Q9H4X1 | chr13: 41,457,559-41,470,882 |
RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
6196 | Q15349 | chr6: 166,409,364-166,906,451 |
S100A11 | S100 calcium binding protein A11 |
6282 | P31949 | chr1: 152,032,506-152,047,907 |
SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
5270 | P07093 | chr2: 223,975,112-224,039,319 |
SFRP1 | secreted frizzled-related protein 1 |
6422 | Q8N474 | chr8: 41,261,958-41,309,497 |
SFRP4 | secreted frizzled-related protein 4 |
6424 | Q6FHJ7 | chr7: 37,905,932-38,025,695 |
SFRP5 | secreted frizzled-related protein 5 |
6425 | Q5T4F7 | chr10: 97,766,751-97,771,952 |
SH3BP4 | SH3-domain binding protein 4 |
23677 | Q9P0V3 | chr2: 234,951,973-235,055,714 |
SIRT2 | sirtuin 2 |
22933 | Q8IXJ6 | chr19: 38,878,555-38,899,862 |
SKAP2 | src kinase associated phosphoprotein 2 |
8935 | O75563 | chr7: 26,667,062-26,995,239 |
SKI | SKI proto-oncogene |
6497 | P12755 | chr1: 2,228,695-2,310,119 |
SMAD1 | SMAD family member 1 |
4086 | Q15797 | chr4: 145,481,194-145,558,079 |
SMAD2 | SMAD family member 2 |
4087 | Q15796 | chr18: 47,808,957-47,931,146 |
SMAD4 | SMAD family member 4 |
4089 | Q13485 | chr18: 51,028,394-51,085,045 |
SMAD6 | SMAD family member 6 |
4091 | O43541 | chr15: 66,702,228-66,782,848 |
SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
6595 | P51531 | chr9: 1,980,290-2,193,624 |
SOD2 | superoxide dismutase 2, mitochondrial |
6648 | P04179 | chr6: 159,669,057-159,762,529 |
SOX4 | SRY-box 4 |
6659 | Q06945 | chr6: 21,592,768-21,598,619 |
SPRY1 | sprouty RTK signaling antagonist 1 |
10252 | O43609 | chr4: 123,396,795-123,403,760 |
SPRY2 | sprouty RTK signaling antagonist 2 |
10253 | O43597 | chr13: 80,335,976-80,340,951 |
SSTR1 | somatostatin receptor 1 |
6751 | P30872 | chr14: 38,207,999-38,213,067 |
SSTR5 | somatostatin receptor 5 |
6755 | P35346 | chr16: 1,078,781-1,080,142 |
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
6774 | P40763 | chr17: 42,313,324-42,388,568 |
STK11 | serine/threonine kinase 11 |
6794 | Q15831 | chr19: 1,177,558-1,228,435 |
STK4 | serine/threonine kinase 4 |
6789 | Q13043 | chr20: 44,966,474-45,079,959 |
TAX1BP3 | Tax1 (human T-cell leukemia virus type I) binding protein 3 |
30851 | O14907 | chr17: 3,662,896-3,668,682 |
TBRG1 | transforming growth factor beta regulator 1 |
84897 | Q3YBR2 | chr11: 124,622,836-124,635,398 |
TES | testin LIM domain protein |
26136 | Q9UGI8 | chr7: 116,210,493-116,258,783 |
TGFB1 | transforming growth factor beta 1 |
7040 | P01137 | chr19: 41,301,587-41,353,911 |
TGFB1I1 | transforming growth factor beta 1 induced transcript 1 |
7041 | O43294 | chr16: 31,471,585-31,477,960 |
TGFB2 | transforming growth factor beta 2 |
7042 | P61812 | chr1: 218,346,235-218,444,619 |
TIMP2 | TIMP metallopeptidase inhibitor 2 |
7077 | P16035 | chr17: 78,852,977-78,925,387 |
TLR2 | toll-like receptor 2 |
7097 | O60603 | chr4: 153,701,500-153,705,699 |
TNFRSF8 | tumor necrosis factor receptor superfamily member 8 |
943 | P28908 | chr1: 12,063,377-12,144,207 |
TNS2 | tensin 2 |
23371 | Q63HR2 | chr12: 53,046,969-53,064,372 |
TOB2 | transducer of ERBB2, 2 |
10766 | Q14106 | chr22: 41,433,492-41,447,023 |
TP53 | tumor protein p53 |
7157 | P04637 | chr17: 7,661,779-7,687,550 |
TP53INP1 | tumor protein p53 inducible nuclear protein 1 |
94241 | Q96A56 | chr8: 94,925,972-94,949,411 |
TSC2 | tuberous sclerosis 2 |
7249 | P49815 | chr16: 2,047,465-2,088,720 |
UTP20 | UTP20 small subunit processome component |
27340 | O75691 | chr12: 101,280,109-101,386,616 |
VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor |
7421 | P11473 | chr12: 47,841,537-47,943,048 |
VEGFC | vascular endothelial growth factor C |
7424 | P49767 | chr4: 176,683,538-176,792,727 |
WT1 | Wilms tumor 1 |
7490 | P19544 | chr11: 32,387,775-32,435,630 |
ZBTB16 | zinc finger and BTB domain containing 16 |
7704 | Q05516 | chr11: 114,059,593-114,250,676 |
ZEB1 | zinc finger E-box binding homeobox 1 |
6935 | P37275 | chr10: 31,318,495-31,529,814 |
ZNF268 | zinc finger protein 268 |
10795 | Q14587 | chr12: 133,181,409-133,214,831 |
ZNF503 | zinc finger protein 503 |
84858 | Q96F45 | chr10: 75,397,830-75,401,906 |